Reuters logo
BRIEF-Alcobra provides update on recent FDA meeting and path forward for MDX clinical development program
January 9, 2017 / 12:33 PM / 8 months ago

BRIEF-Alcobra provides update on recent FDA meeting and path forward for MDX clinical development program

Jan 9 (Reuters) - Alcobra Ltd

* Alcobra provides update on recent FDA meeting and path forward for MDX clinical development program

* Top-line results from measure study to be reported in coming weeks

* FDA to modify clinical hold from full to partial to allow conduct of a Phase I safety study Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below